肥胖症手术中早期出血并发症的术前危险因素：病例对照研究。
Preoperative risk factors for early hemorrhagic complications in bariatric surgery: a case-control study.
机构信息
General Surgery Department. Clínica Juan N Corpas, Universidad Nacional de Colombia, Bogotá, Colombia.
General Surgery Department. Bariatric Surgery Unit, Hospital Clínico Universitario, Avenida Blasco Ibáñez 17, 46010, Valencia, Spain.
出版信息
Surg Endosc. 2022 Jan;36(1):430-434. doi: 10.1007/s00464-021-08302-7. Epub 2021 Feb 1.
BACKGROUND
Although a reliable procedure in morbid obesity treatment, bariatric surgery may be associated with serious complications such as leakage or bleeding. We aimed to analyze the preoperative factors involved in patients with early postoperative hemorrhage after any type of bariatric surgery who required conservative treatment or reoperation for this complication.
METHODS
Retrospective case-controlled study (1:3) of 2 patient cohorts (postoperative bleeding/controls) matched by type of surgical intervention.
RESULTS
Hypertension (Odds Ratio 5.029; 95% Confidence Interval 1.78-14.13) and history of antiplatelet medication (OR 13.263; 95% CI 1.39-125.9) were independent risk factors in the bivariate analyses, confirmed in the logistic regression model on multivariate analysis.
CONCLUSIONS
With no between-group differences in Body Mass Index (BMI) and type 2 Diabetes (T2D), early hemorrhagic complications were found to be more frequent in patients with hypertension or antiplatelet drug treatment.
背景
尽管减重手术是治疗病态肥胖症的可靠方法，但它可能会导致严重的并发症，如漏液或出血。我们旨在分析任何类型的减重手术后需要保守治疗或再次手术以治疗这种并发症的患者的术后早期出血的术前相关因素。
方法
回顾性病例对照研究（1:3），比较了两组患者（术后出血/对照组），按手术干预类型进行匹配。
结果
高血压（比值比 5.029；95%置信区间 1.78-14.13）和抗血小板药物史（OR 13.263；95%CI 1.39-125.9）是二变量分析中的独立危险因素，在多变量分析的逻辑回归模型中得到证实。
结论
在 BMI 和 2 型糖尿病（T2D）无组间差异的情况下，高血压或抗血小板药物治疗的患者发生早期出血并发症更为频繁。
Zotero 插件